Fairfax Financial Limite... (FRFHF)
OTC: FRFHF
· Real-Time Price · USD
1707.24
-3.76 (-0.22%)
At close: Aug 14, 2025, 3:50 PM
1708.63
0.08%
After-hours: Aug 14, 2025, 03:50 PM EDT
Revenue by Geography
Period Ending | Dec 31, 2024 |
---|---|
Middle East And Asia Revenue | 5.25B |
Middle East And Asia Revenue Growth | n/a |
Operating Expense Breakdown
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | n/a | 1.82B | 1.3B | 1.29B | 95.7M | 90.7M | 158.2M | 75.5M | 90M | 106.5M | 931M | 705.4M | 756.7M | 761.4M | 2.05B | 683.1M | 342.3M | 684.8M | 203.2M | 336.4M | 243.9M | 358.4M | 436.1M | 418.9M | 365.6M | 327.7M | 383.8M | 325.2M | 319.8M | 286.2M | 629.9M | 257.1M | 240.9M | 214.7M | 439.9M | 390.3M | 379.1M | 388.4M | 408.2M | 394.1M | 346.8M | 321M |
Selling, General, and Administrative Revenue Growth | -100.00% | +40.05% | +0.72% | +1247.75% | +5.51% | -42.67% | +109.54% | -16.11% | -15.49% | -88.56% | +31.98% | -6.78% | -0.62% | -62.91% | +200.56% | +99.56% | -50.01% | +237.01% | -39.60% | +37.93% | -31.95% | -17.82% | +4.11% | +14.58% | +11.57% | -14.62% | +18.02% | +1.69% | +11.74% | -54.56% | +145.00% | +6.72% | +12.20% | -51.19% | +12.71% | +2.95% | -2.39% | -4.85% | +3.58% | +13.64% | +8.04% | n/a |
Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |